Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Nanexa AB (NANEXA) Stock Price & Analysis

2 Followers

NANEXA Stock Chart & Stats

kr 9.93-kr 0.15(-1.49%)
At close: 5:30 PM GMT+1
kr 5kr 7.5kr 10Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
SEK 9.58 - SEK 10.12
52-Week Range
SEK 1.46 - SEK 15.50
Previous Close
SEK 10.08
Volume
N/A
Average Volume (3M)
1.96M
Market Cap
SEK 1.90B
Enterprise Value
SEK 2.04B
Total Cash (Recent Filing)
SEK 52.56M
Total Debt (Recent Filing)
SEK 795.00K
Price to Earnings (P/E)
―
Beta
0.22
Next Earnings
Feb 12, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

PharmaShell Platform

The PharmaShell platform addresses an important pharmaceutical development need by targeting sustained drug release and more convenient dosing. If technical development succeeds, this capability could support differentiated injectable medicines and create durable partnering opportunities across multiple drug programs.

Partnering-based Monetization

A partnering and licensing model can let Nanexa monetize its technology without bearing the full cost of commercializing every medicine itself. Upfront payments, development milestones and royalties provide several potential revenue streams as partner programs progress.

Low Financial Leverage

Very low leverage gives Nanexa greater financial flexibility than a heavily indebted development company. Limited debt exposure reduces fixed financing pressure and leaves more room to direct available resources toward PharmaShell development and partner-related activities.

Bears Say

Sharp Revenue Decline

The sharp TTM revenue contraction indicates that commercial or development income has not yet developed into a stable growth trajectory. Continued volatility makes planning more difficult and weakens confidence that the platform is currently translating into scalable operating revenue.

Persistent Cash Burn

Sustained operating and free-cash-flow deficits mean Nanexa continues to consume cash to fund its activities rather than supporting them internally. Unless operations improve, ongoing development may require additional financing, which can constrain strategic flexibility over time.

Negative Shareholder Returns

Meaningfully negative return on equity shows that the company is not yet generating an economic return on shareholders’ capital. Persistent losses can erode the value of invested resources and make future funding or partnership negotiations more important to continued development.

Nanexa AB News

NANEXA FAQ

What was Nanexa AB’s price range in the past 12 months?
Nanexa AB lowest stock price was kr 1.46 and its highest was kr 15.50 in the past 12 months.
What is Nanexa AB’s market cap?
Nanexa AB’s market cap is kr 1.90B.
When is Nanexa AB’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nanexa AB’s earnings last quarter?
Nanexa AB released its earnings results on Nov 05, 2026. The company reported kr 0.823 earnings per share for the quarter.
Is Nanexa AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Nanexa AB pay dividends?
Nanexa AB does not currently pay dividends.
What is Nanexa AB’s EPS estimate?
Nanexa AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nanexa AB have?
Nanexa AB has 191,036,530 shares outstanding.
What happened to Nanexa AB’s price movement after its last earnings report?
Nanexa AB reported an EPS of kr 0.823 in its last earnings report. Following the earnings report the stock price went down -3.263%.
Which hedge fund is a major shareholder of Nanexa AB?
Currently, no hedge funds are holding shares in SE:NANEXA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology